Corey Williams
Corey Williams's Latest Posts
SET Portfolio Update January 2014
January 7, 2014 Happy New Year! Over the last year, we recommended 15 ETFs. We currently have 11 open positions that are all showing solid gains…. Eight of them are up double digits. We also sold 13 ETFs last year. 12 out of the 13 ETFs we sold last year for profit. The average gain […]
BST Position Update – December 30, 2013
December 30, 2013 ***Special Trade Update***Hey folks, With 2013 quickly drawing to a close, I’d like to take a few minutes to share my thoughts about a biotech stock that I’m particularly excited about for 2014. You see, if all goes as planned with a certain company’s leading drug candidate, its stock price could skyrocket […]
BST Special Trade Update: December 30, 2013
December 30, 2013 ***Special Trade Update***Hey folks, With 2013 quickly drawing to a close, I’d like to take a few minutes to share my thoughts about a biotech stock that I’m particularly excited about for 2014. You see, if all goes as planned with a certain company’s leading drug candidate, its stock price could […]
BST Trade Alert: December 19, 2013
December 19, 2013 Recommendation: Buy Conatus Pharmaceuticals (NASDAQ: CNAT) up to $7.00 per share. About the Company: Conatus is an innovative biotech focusing on the development of novel medicines to treat liver disease. The company was founded in 2005, but it just completed its initial public offering in July 2013. In other words, Conatus is not only […]
SET Monthly Issue December 2013
December 2013 ‘TIS THE SEASON FOR A SANTA CLAUS RALLY Happy Holidays! It’s the time of year for last minute Christmas shopping, celebrating with family and friends, and setting goals for 2014. It’s also a great time of year for the stock market… The Santa Claus rally is about to begin. This period from around […]
BST Position Update: December 17, 2013
December 17, 2013 . . . . Anacor Pharmaceuticals (NASDAQ: ANAC) – Sell ANAC has been an outstanding performer for the portfolio. After dropping to a low of $3.00 in February, the stock has increased more than five-fold in the past ten months. As a result, we’re now sitting on gains of 245%! With the […]
SET Portfolio Update December 2013
December 3, 2013 Happy Holidays! It’s hard to believe 2013 is nearly over. It has flown by… As we wind down the last few weeks of 2013, the stock market continues to push higher. The S&P 500 climbed to a new all-time high of 1,813 on Friday. Amazingly, the large cap index is up more […]
BST Trade Alert: November 26, 2013
November 26, 2013 Recommendation: Buy Venaxis (NASDAQ: APPY) up to $2.15 per share. About the Company: Venaxis is a Colorado-based biotech that was initially formed in 2000 to produce purified proteins for diagnostic applications. Since then, the company’s mission has evolved into developing diagnostic products with high profit margin potential. The company’s leading product candidate is a […]
BST Position Update: November 21, 2013
November 21, 2013 . . . . BioLineRx (NASDAQ: BLRX) – Sell BLRX has been a great performer for the portfolio. As I write we’re sitting on a terrific 55% gain on the position. Not bad for a stock that lost more than half its value on one bad day in March. We fully expected the stock […]
SET Monthly Issue November 2013
November 2013 FED’S NEXT CHAIRWOMAN SENDS STOCKS ‘YELLEN’ HIGHER Janet Yellen is set to succeed Ben Bernanke as the next Chairman of the Federal Reserve. Her discussion with the Senate last week as she seeks to advance her confirmation sent stocks to new highs. The S&P 500 closed at an all-time high of 1,798 on […]
